Merlin Capital LLC
- SEC CIK
- 0001911169
- Latest filing
- May 13, 2024
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Merlin Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q1 2024 holdings
- Shares (Q1 2024)
- 8,879
- Value
- $605.2K
- % of portfolio
- 1.8%
- Quarters held
- 7
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 8,879 | $605.2K | 1.8% | −46−0.5% | Reduced | Holders |
| Q4 2023 | 8,925 | $558.7K | 1.8% | −167−1.8% | Reduced | Holders |
| Q3 2023 | 9,092 | $412.7K | 1.5% | +290+3.3% | Added | Holders |
| Q2 2023 | 8,802 | $494.1K | 1.7% | +1,517+20.8% | Added | Holders |
| Q1 2023 | 7,285 | $329.5K | 1.2% | +476+7.0% | Added | Holders |
| Q4 2022 | 6,809 | $276.8K | 0.7% | +754+12.5% | Added | Holders |
| Q3 2022 | 6,055 | $396.0K | 0.9% | +6,055 | New | Holders |